Fasting-induced metabolic reprogramming as a therapeutic vulnerability in cancer: a systematic mechanistic review of in vitro evidence

Rihab Bensalek, Hind Hassani Idrissi, Atmane Ait Baha, Meryem Hicham, Omar Akhouayri, Mouna Habbane, Bouchra Benazzouz

Open source

DOI
10.1007/s12032-026-03391-7
Published
2026-09-25
Container
Medical Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12032-026-03391-7,
  title = {Fasting-induced metabolic reprogramming as a therapeutic vulnerability in cancer: a systematic mechanistic review of in vitro evidence},
  author = {Rihab Bensalek and Hind Hassani Idrissi and Atmane Ait Baha and Meryem Hicham and Omar Akhouayri and Mouna Habbane and Bouchra Benazzouz},
  year = {2026},
  journal = {Medical Oncology},
  doi = {10.1007/s12032-026-03391-7},
  url = {https://doi.org/10.1007/s12032-026-03391-7}
}

RIS

TY  - JOUR
TI  - Fasting-induced metabolic reprogramming as a therapeutic vulnerability in cancer: a systematic mechanistic review of in vitro evidence
AU  - Rihab Bensalek
AU  - Hind Hassani Idrissi
AU  - Atmane Ait Baha
AU  - Meryem Hicham
AU  - Omar Akhouayri
AU  - Mouna Habbane
AU  - Bouchra Benazzouz
PY  - 2026
JO  - Medical Oncology
DO  - 10.1007/s12032-026-03391-7
UR  - https://doi.org/10.1007/s12032-026-03391-7
ER  - 

APA

Bensalek, R., Idrissi, H. H., Baha, A. A., Hicham, M., Akhouayri, O., Habbane, M., & Benazzouz, B. (2026). Fasting-induced metabolic reprogramming as a therapeutic vulnerability in cancer: a systematic mechanistic review of in vitro evidence. Medical Oncology. https://doi.org/10.1007/s12032-026-03391-7

Source records